Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

Although next-generation sequencing (NGS) has helped characterize the complex genomic landscape of myeloid malignancies, its clinical utility remains undefined. This has resulted in variable funding for NGS testing, limiting its accessibility. At our center, targeted sequencing (TAR-SEQ) using a 54-...

Descripción completa

Detalles Bibliográficos
Autores principales: Alduaij, Waleed, McNamara, Caroline J., Schuh, Andre, Arruda, Andrea, Sukhai, Mahadeo, Kanwar, Nisha, Thomas, Mariam, Spiegel, Jay, Kennedy, James A., Stockley, Tracy, Tsui, Hubert, Devlin, Rebecca, Sibai, Hassan, Maze, Dawn, Schimmer, Aaron, Yee, Karen, Chan, Steven, Kamel-Reid, Suzanne, Gupta, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745993/
https://www.ncbi.nlm.nih.gov/pubmed/31723772
http://dx.doi.org/10.1097/HS9.0000000000000044

Ejemplares similares

Ejemplares similares